WO2023131871 - AND-GATE ALLOSTERIC PROTEIN-BASED SWITCHES
National phase entry:
Publication Number
WO/2023/131871
Publication Date
13.07.2023
International Application No.
PCT/IB2023/020001
International Filing Date
04.01.2023
Title **
[English]
AND-GATE ALLOSTERIC PROTEIN-BASED SWITCHES
[French]
COMMUTATEURS À BASE DE PROTÉINE ALLOSTÉRIQUE DE PORTE ET
Applicants **
QUEENSLAND UNIVERSITY OF TECHNOLOGY
Inventors
ALEXANDROV, Kirill
GUO, Zhong
Priority Data
2200051.7
05.01.2022
GB
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP Australia
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3153 | |
| EPO | Filing, Examination, Granting | 19812 | |
| Japan | Filing, Examination, Granting | 2487 | |
| South Korea | Filing, Examination, Granting | 2769 | |
| USA | Filing, Examination, Granting | 8590 |
Total:
36,811
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to improved protein-based biosensors that are suitable for detection of one or more target molecules in a sample. The biosensors are fully-reversible with dynamic ranges suitable for analytic and diagnostic applications. The biosensors of the present invention may be used in synthetic biology, for example in constructing artificial cellular or extracellular signalling networks.[French]
La présente invention concerne des biocapteurs à base de protéines améliorés étant appropriés pour la détection d'une ou de plusieurs molécules cibles dans un échantillon. Les biocapteurs sont entièrement réversibles avec des plages dynamiques appropriées pour des applications analytiques et diagnostiques. Les biocapteurs de la présente invention peuvent être utilisés en biologie synthétique, par exemple dans la construction de réseaux de signalisation cellulaires ou extracellulaires artificiels.